Waldencast completes sale of Obagi Medical to Bridgepoint valued up to $460 million

Reuters2026/07/30 21:05

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Waldencast completed the sale of Obagi Medical to Bridgepoint in a deal valued at up to USD 460 million, subject to customary closing adjustments.
Proceeds were used to repay all outstanding senior term loan facility borrowings, strengthening the balance sheet.
The group will focus on accelerating global growth at Milk Makeup, its remaining brand.
Founders Michel Brousset and Hind Sebti, alongside CFO Manuel Manfredi, will move to lead Obagi Medical with Bridgepoint.
Executive Chairman Felipe Dutra will serve as principal executive officer and principal financial officer.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Waldencast plc published the original content used to generate this news brief on July 30, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Waldencast completes sale of Obagi Medical to Bridgepoint valued up to $460 million

You may also like

Crypto prices